Tasso's FDA 510(k)-cleared micro-collection devices power the RedDrop Dx at-home collection module. Virtually painless, clinical-grade blood samples in under 5 minutes — no phlebotomist, no lab visit, no needles.

Traditional blood draws require scheduling, travel, and needles. Tasso's FDA-cleared micro-collection technology eliminates all three — delivering clinical-grade samples from the patient's home.
Class II medical device cleared by the FDA for at-home capillary blood micro-collection. Clinical-grade samples without a phlebotomist.
Proprietary gentle vacuum technology draws blood from capillaries under the skin. No needles, no lancets — patients barely feel it.
Complete sample collection in under 5 minutes from the comfort of home. No scheduling, no waiting rooms, no travel.
Pre-assembled collection kits ship directly to the patient's door with clear instructions and a prepaid return mailer.
Maintains sample integrity for sensitive biomarkers including hormones, metabolic panels, and genomic assays.
Samples ship directly to CLIA-certified partner laboratories for processing. Results flow back into the Omni Genomix platform automatically.
The entire at-home collection process — from ordering the kit to receiving lab results — is automated through the Omni Genomix platform. Practitioners order, patients collect, labs process, results flow.

Practitioner orders an at-home collection kit through the Omni Genomix dashboard. Kit is dispatched directly to the patient.
Patient applies the Tasso device to the upper arm. Gentle vacuum draws a micro-sample in under 5 minutes — virtually painless.
Patient seals the sample in the included prepaid mailer and drops it at any postal location. Cold-chain packaging maintains integrity.
CLIA-certified lab processes the sample. Results flow directly into the patient's portal and the practitioner's dashboard.
Traditional at-home collection methods compromise on sample quality. Tasso's FDA-cleared technology delivers samples equivalent to venipuncture — opening at-home testing to panels that previously required a lab visit.
Tasso's patented vacuum technology eliminates needles entirely. Patients apply a small device to the upper arm and collect a clinical-grade sample in minutes — no pain, no anxiety, no phlebotomist required.
Tasso powers the RedDrop Dx at-home collection module within Omni Genomix. Specimen tracking, kit logistics, and lab routing are fully automated through the platform.
FDA 510(k)-cleared Class II medical device delivers samples equivalent to traditional venipuncture. Validated for a wide range of biomarker panels including hormones, metabolics, and genomics.
Remote patient testing completion rates jump from ~60% with traditional phlebotomy to over 92% with Tasso at-home collection. Patients actually complete their lab work.
Ship collection kits to patients anywhere in the continental United States. No geographic restrictions, no mobile phlebotomy scheduling, no lab visit coordination.
At-home collection opens new revenue streams for practitioners. Capture lab testing revenue from remote patients, reduce no-shows, and increase panel completion rates across your entire patient base.
"Since integrating Tasso at-home collection, our remote patient completion rate went from 60% to 92%. Patients love the convenience and we love the revenue uplift."
"I hate needles. Always have. The Tasso device was so easy — I barely felt anything. Did the whole thing on my couch in about 3 minutes. Game changer."
"The cold-chain compatibility means I can order sensitive hormone panels for remote patients without worrying about sample degradation. It just works."
Tasso's technology powers a complete at-home collection ecosystem within Omni Genomix — from the micro-collection device itself to specimen tracking, cold-chain logistics, and automated lab results delivery.
Core Hardware
FDA 510(k)-cleared Class II micro-collection device. Proprietary gentle vacuum technology draws capillary blood from the upper arm — virtually painless, no needles, clinical-grade quality.
Logistics Platform
Pre-assembled collection kits with Tasso device, instructions, sample stabilizer, and prepaid return mailer. Automated kit dispatch through the Omni Genomix dashboard.
Quality Assurance
End-to-end specimen tracking from kit dispatch to lab receipt. Barcode scanning, temperature monitoring, and chain-of-custody documentation for regulatory compliance.
Sample Integrity
Proprietary packaging maintains sample integrity during transit for sensitive biomarkers. Compatible with hormone panels, metabolic assays, and genomic testing.
Data Pipeline
Results from CLIA-certified partner labs flow directly into the Omni Genomix platform. Practitioners see results in their dashboard; patients access them through the patient portal.
Engagement Layer
Guided collection experience with step-by-step instructions, SMS/email notifications for kit status, and educational content about their upcoming lab results.
Tasso integrates natively with every module in the Omni Genomix ecosystem. At-home collection feeds into diagnostics, telehealth, pharmacy, and genomics — creating a seamless patient journey from sample to treatment.

PrymDx LIMS
PRYM Wellness
GetLabs
Spot DxSee how practitioners across the country are transforming their practices with Tasso — measured in revenue, efficiency, and patient outcomes.
MD, PhD — Endocrinology
Hormone therapy patients need monthly monitoring but only 45% were completing their scheduled labs. The inconvenience of venipuncture visits caused patients to skip monitoring, leading to suboptimal dosing and safety concerns.
Deployed Tasso micro-collection devices for monthly hormone monitoring. Patients self-collect at home with a painless push-button device, mail the sample back, and results integrate directly into PrymDx LIMS.
Monitoring Compliance
+102% adherence
Dose Adjustments/Year
3x more precise
Adverse Events
-75% incidents
Lab Revenue
+138% growth
"Monthly hormone monitoring compliance went from 45% to 91% — that's not just a revenue number, it's a patient safety number. I can now adjust TRT and thyroid dosing based on actual monthly data instead of guessing between quarterly visits. Two patients had early thyroid issues caught that we would have missed."
— Dr. Emily Sato, MD, PhD — Endocrinology
MD — Pediatric Integrative
Pediatric blood draws are traumatic — 60% of parents refused recommended lab work for their children due to needle anxiety. Practice was losing $180K/year in uncompleted pediatric labs and missing critical nutritional deficiencies.
Introduced Tasso micro-collection for all pediatric patients over age 4. The painless, needle-free device was positioned as a 'superhero sticker' experience. Parents self-administer at home with video guidance.
Lab Acceptance Rate
+130% compliance
Recovered Revenue
+$180K/year
Child Pain Score
-89% pain
Deficiencies Caught
+325% detection
"Parents literally cried with relief when I showed them the Tasso device. Their kids had been traumatized by traditional blood draws. Now 92% of parents complete the labs I order, and the kids think it's a cool sticker. We caught iron deficiencies and vitamin D issues in dozens of kids who would have gone undiagnosed."
— Dr. Robert Okafor, MD — Pediatric Integrative
Traditional venipuncture creates barriers for remote monitoring, clinical trials, and patient compliance. Tasso's micro-collection technology removes them all.
Patients avoid routine blood monitoring because venipuncture is painful and inconvenient
Push-button micro-collection device that painlessly collects capillary blood in under 5 minutes — no needles, no phlebotomist required
4x increase in patient monitoring compliance
Remote patient monitoring requires frequent lab visits that patients won't attend
Ship-to-home micro-collection kits enabling weekly or monthly monitoring without leaving home, with prepaid return logistics
Enable true longitudinal monitoring with 90%+ compliance
Capillary blood samples historically had limited analytical validity vs. venous draws
FDA-cleared collection technology validated for 100+ analytes with venous-equivalent accuracy, including hormones, metabolites, and genomic markers
Clinical-grade results from 0.1mL micro-samples
Clinical trial enrollment suffers when participants must travel to draw sites
Decentralized trial collection enabling participants to self-collect at home, expanding geographic reach and reducing dropout rates
60% faster enrollment and 45% lower dropout rates
Cold-chain requirements for blood samples limit shipping windows and increase costs
Proprietary stabilization technology maintaining sample integrity at ambient temperature for up to 7 days during transit
Ship samples via standard mail — no cold-chain needed
Pediatric blood collection is traumatic for children and stressful for parents
Virtually painless micro-collection designed for all ages — no needles visible, minimal blood volume, and child-friendly device design
95% of pediatric patients report zero pain during collection
Every partner in the Omni Genomix ecosystem is connected. Data flows seamlessly between layers — no silos, no manual handoffs.

Tasso
CurrentData Transferred
Micro-collection specimen
Device serial number
Collection timestamp
Sample volume data
Data Transferred
Device telemetry
Patient self-collection log
Sample quality metrics
Chain of custody
Join the Omni Genomix waitlist to offer your patients Tasso-powered at-home blood collection. Increase completion rates, expand your reach, and unlock new revenue streams.